B
DXCM icon

Bayban’s DexCom DXCM Stock Holding History

Bayban’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15K Hold
17
– – ﹤0.01% 559
2026
Q1 		$1.07K Hold
17
– – ﹤0.01% 613
2025
Q4 		$1.13K Buy
+17
New +$1.1K ﹤0.01% 567

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bayban's DXCM Position: Q2 2026 in Review

Bayban held its DexCom (DXCM) position steady in Q2 2026 at 17 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #559.

Bayban first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. 919 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Bayban held 17 shares of DexCom worth $1.15K as of Q2 2026.
  • Bayban left its DexCom share count unchanged in Q2 2026.
  • DexCom made up ﹤0.01% of Bayban's portfolio in Q2 2026, its #559 holding.
  • Bayban first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
  • 919 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.